‘Amazing’ trial shows drug combination stops lung cancer advancing for longer
Favicon 
notallnewsisbad.com

‘Amazing’ trial shows drug combination stops lung cancer advancing for longer

Exclusive: Global trial finds treatment with amivantamab and lazertinib halts progression for average of 23.7 months Source: ‘Amazing’ trial shows drug combination stops lung cancer advancing for longer Wow!